OrganiGram Holdings Inc
NASDAQ:OGI
OrganiGram Holdings Inc
OrganiGram Holdings, Inc. engages in the production and sale of medical marijuana. The company is headquartered in Moncton, New Brunswick. The company went IPO on 2011-11-24. Organigram is a licensed producer of cannabis and extract-based products. The firm is focused on producing, indoor-grown cannabis for patients and adult recreational consumers in Canada. Organigram is permitted to possess, produce, sell, provide, ship, deliver and transport cannabis, cannabis plants and cannabis oil. The company is also authorized for wholesale shipping of cannabis plant cuttings, dried flower, blends, pre-rolls and cannabis oil to approved retailers and wholesalers for adult-use recreational cannabis under individual provincial and territorial regulations as per Cannabis Act. Organigram distributes its products mainly through the Company’s online store or by phone. Organigram has also developed a portfolio of legal adult use recreational cannabis brands, including The Edison Cannabis Company, SHRED, ANKR Organics, Indi, Bag o’ Buds and Trailblazer.
OrganiGram Holdings, Inc. engages in the production and sale of medical marijuana. The company is headquartered in Moncton, New Brunswick. The company went IPO on 2011-11-24. Organigram is a licensed producer of cannabis and extract-based products. The firm is focused on producing, indoor-grown cannabis for patients and adult recreational consumers in Canada. Organigram is permitted to possess, produce, sell, provide, ship, deliver and transport cannabis, cannabis plants and cannabis oil. The company is also authorized for wholesale shipping of cannabis plant cuttings, dried flower, blends, pre-rolls and cannabis oil to approved retailers and wholesalers for adult-use recreational cannabis under individual provincial and territorial regulations as per Cannabis Act. Organigram distributes its products mainly through the Company’s online store or by phone. Organigram has also developed a portfolio of legal adult use recreational cannabis brands, including The Edison Cannabis Company, SHRED, ANKR Organics, Indi, Bag o’ Buds and Trailblazer.
Record Revenue: Organigram delivered record quarterly and full year revenue in fiscal 2025, with Q4 net revenue rising 79% to $80.1 million and full year net revenue up 62% to $259.2 million.
Margin Expansion: Adjusted gross margin reached 38% in Q4 and 35% for the year, both improvements over the prior periods, and management expects further margin gains in 2026.
International Growth: International sales reached a company high of $26.3 million, up 171%, supported by expansion into Germany, the UK, Australia, and the US.
Motif Acquisition: The Motif Labs acquisition drove cost synergies and did not dilute market share, contributing to improved operational leverage.
Guidance Raised: Fiscal 2026 net revenue is expected to exceed $300 million, with further margin and adjusted EBITDA growth and positive free cash flow projected.
Market Leadership: Organigram held the #1 Canadian market share at 11.9% in 2025 and led in most major provinces.
CEO Transition: James Yamanaka will become CEO in early January, bringing international growth experience.
